Immunovant, Inc. (IMVT) SEC Filings https://www.immunovant.com/investors/sec-filings/all-sec-filings/rss Immunovant, Inc. (IMVT) - All SEC Filings en-us https://d1io3yog0oux5.cloudfront.net/_d6ae8ad1fc90c30ceeec0c8ff3e3b1be/immunovant/files/theme/images/logo-sm.jpg Immunovant, Inc. Logo /investors Equisolve Investor Relations Suite <![CDATA[S-3ASR - Automatic shelf registration statement of securities of well-known seasoned issuers]]> https://www.immunovant.com/investors/sec-filings/all-sec-filings/content/0001764013-26-000124/0001764013-26-000124.pdf Mon, 09 Nov 26 07:46:52 -0500 https://www.immunovant.com/investors/sec-filings/all-sec-filings/content/0001764013-26-000124/0001764013-26-000124.pdf <![CDATA[10-Q - Quarterly report [Sections 13 or 15(d)]]]> https://www.immunovant.com/investors/sec-filings/all-sec-filings/content/0001764013-26-000122/0001764013-26-000122.pdf Mon, 09 Nov 26 07:21:50 -0500 https://www.immunovant.com/investors/sec-filings/all-sec-filings/content/0001764013-26-000122/0001764013-26-000122.pdf <![CDATA[8-K - Current report]]> https://www.immunovant.com/investors/sec-filings/all-sec-filings/content/0001764013-26-000121/0001764013-26-000121.pdf Mon, 09 Nov 26 07:09:51 -0500 https://www.immunovant.com/investors/sec-filings/all-sec-filings/content/0001764013-26-000121/0001764013-26-000121.pdf <![CDATA[4 - Statement of changes in beneficial ownership of securities]]> https://www.immunovant.com/investors/sec-filings/all-sec-filings/content/0001764013-26-000117/0001764013-26-000117.pdf Fri, 30 Oct 26 16:37:33 -0400 https://www.immunovant.com/investors/sec-filings/all-sec-filings/content/0001764013-26-000117/0001764013-26-000117.pdf <![CDATA[4 - Statement of changes in beneficial ownership of securities]]> https://www.immunovant.com/investors/sec-filings/all-sec-filings/content/0001764013-26-000114/0001764013-26-000114.pdf Fri, 23 Oct 26 16:57:43 -0400 https://www.immunovant.com/investors/sec-filings/all-sec-filings/content/0001764013-26-000114/0001764013-26-000114.pdf <![CDATA[4 - Statement of changes in beneficial ownership of securities]]> https://www.immunovant.com/investors/sec-filings/all-sec-filings/content/0001702969-26-000012/0001702969-26-000012.pdf Fri, 09 Oct 26 17:06:17 -0400 https://www.immunovant.com/investors/sec-filings/all-sec-filings/content/0001702969-26-000012/0001702969-26-000012.pdf <![CDATA[4 - Statement of changes in beneficial ownership of securities]]> https://www.immunovant.com/investors/sec-filings/all-sec-filings/content/0001779707-26-000009/0001779707-26-000009.pdf Fri, 09 Oct 26 17:05:37 -0400 https://www.immunovant.com/investors/sec-filings/all-sec-filings/content/0001779707-26-000009/0001779707-26-000009.pdf <![CDATA[4 - Statement of changes in beneficial ownership of securities]]> https://www.immunovant.com/investors/sec-filings/all-sec-filings/content/0001764013-26-000112/0001764013-26-000112.pdf Fri, 09 Oct 26 17:04:30 -0400 https://www.immunovant.com/investors/sec-filings/all-sec-filings/content/0001764013-26-000112/0001764013-26-000112.pdf <![CDATA[4 - Statement of changes in beneficial ownership of securities]]> https://www.immunovant.com/investors/sec-filings/all-sec-filings/content/0001764013-26-000110/0001764013-26-000110.pdf Mon, 05 Oct 26 19:42:53 -0400 https://www.immunovant.com/investors/sec-filings/all-sec-filings/content/0001764013-26-000110/0001764013-26-000110.pdf <![CDATA[4 - Statement of changes in beneficial ownership of securities]]> https://www.immunovant.com/investors/sec-filings/all-sec-filings/content/0001764013-26-000108/0001764013-26-000108.pdf Fri, 25 Sep 26 16:07:19 -0400 https://www.immunovant.com/investors/sec-filings/all-sec-filings/content/0001764013-26-000108/0001764013-26-000108.pdf